A group of scientists from Monash University and King’s College London has developed a database of information that may help researchers find the link between type 2 diabetes and the coronavirus. The group designed the database for the following reasons: first, the increasing evidence that suggests that the coronavirus can actually cause individuals to become diabetic, and second, when compared to the general population, individuals who have type 2 diabetes are more likely to experience serious coronavirus symptoms and to die from the disease. Type 2 diabetes is a chronic condition that impacts the way the body processes blood sugar.
The database, dubbed the COVIDIAB registry, has been created to assist medical researchers to understand the association between diabetes and the coronavirus. The data that was gathered from patients included whether the diagnoses were new onset. The researchers suggest that the amount of data will increase as researchers learn more about the effect of the coronavirus…
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://ibn.fm/RYAH
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork.